Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)

NCT00508924 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease
Angina, Unstable

Interventions

DRUG: Argatroban
DRUG: Argatroban
DRUG: Argatroban
DRUG: Heparin

Sponsor

Tanabe Pharma Corporation